Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Glyphosate Sales To Exceed $10B by 2021, Despite Cancer Concerns: Report February 8, 2017 Irvin Jackson Add Your Comments Amid continuing concerns about the risk of cancer from Roundup and other glyphosate-based herbicides, a new report suggests that use of the weedkillers is expected to continue to increase over the next six years, potentially generating $10 billion in annual sales by 2021. A report released by Market Research Engine (purchase required) indicates that the global glyphosate sales, consisting mostly of Monsanto’s Roundup, will grow by 7% in the next few years, as more and more of the controversial weedkiller is applied worldwide. The report indicates that the growth will be driven by increasing use in the Asia Pacific region, which is both the largest and fastest growing market for glyphosate products. China and India are identified as the two countries leading the growth in Roundup and glyphosate use in that region. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION However, the report comes at a time when the U.S. and Europe, current leaders in glyphosate use, are evaluating and debating the safety of Roundup and gylphosate, due to concerns that exposure may increase the risk of non-Hodgkins lymphoma and other forms of cancer. Some western countries have placed bans or restrictions on Roundup use in recent years, and California is poised to require the herbicide to carry cancer warnings on its label for the first time. The Market Research Engine report suggests that the increased use in Asia will more than offset any reduced use in the western world, if such reductions even occur. Glyphosate Safety Risks Concerns about the safety of glyphosate arose after the World Health Organization’s International Agency for Research on Cancer (IARC) listed Roundup and other herbicides containing the active ingredient as potential human carcinogens in March 2015. Monsanto has maintained that there is no reliable evidence of a link between Roundup and cancer, suggesting that the IARC’s conclusions were agenda-driven and based on “junk science.” However, many health experts have stood behind the cancer group’s decision, pointing to prior evidence that suggests exposure to Roundup may cause non-Hodgkin’s lymphoma or other forms of cancer. In December, the U.S. Environmental Protection Agency (EPA) held a four-day hearing on glyphosate safety, with a panel of scientific advisers questioning the agency’s methodologies on determining that the weed killer was safe. The panel has 90 days to pour over the testimony, literature and evidence presented during the hearing, after which it will submit recommendations to the EPA. Those recommendations are non-binding, but usually have significant influence on the agency’s final decisions. Monsanto now faces a growing number of Roundup cancer lawsuits filed throughout the United States, typically involving individuals diagnosed with a form of non-Hodgkin’s lymphoma following heavy exposure to the herbicide as a farm or agricultural worker. The complaints allege that the manufacturer recklessly promoted Roundup and pushed greater and greater use of the chemical, without disclosing the potential health risks. A recent U.S. Geological Survey on glyphosate usage nationwide found that an estimated 2.6 billion pounds of the herbicide has been sprayed on America’s agricultural land over the two decades since the mid-1990s, when Monsanto introduced “Roundup Ready” crops that are designed to survive being sprayed with glyphosate, killing the weeds but not the crops. The lawsuits over Roundup allege that plaintiffs may have avoided a diagnosis of non-Hodgkin’s lymphoma or other cancers if they had been warned about the Roundup risks for farmers, landscapers and others in the agricultural industry, as safety precautions could have been taken or other products could have been used to control the growth of weeds. Last month, a California judge rejected attempts by Monsanto to keep cancer warnings for Roundup weedkillers off the product label, after the manufacturer challenged a proposal by the California Office of Environmental Health Hazard Assessment to add glyphosate to a lost of cancer-causing chemicals that require label warnings to be sold in the state. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Glyphosate, Herbicide, Monsanto, Non-Hodgkins Lymphoma, Roundup, Weed Killer More Roundup Lawsuit Stories Bayer’s Roundup Lawsuit Payouts Result in Another $1.37B in Reserves August 4, 2025 Roundup Non-Hodgkin’s Lymphoma Lawsuit Remanded From MDL for Trial July 25, 2025 New Study Appears To Confirm Link Between Roundup and Cancer July 7, 2025 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (Posted: today) Breast mesh products marketed as “internal bras” for lift and augmentation surgeries are now under investigation amid reports of painful complications, and questions over manufacturers’ prior knowledge of mesh-related risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Problems Prompted FDA Warnings Over Off-Label Use (10/15/2025)Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023) Four BioZorb Breast Marker Lawsuits Set for Trial Between Jan. and April 2026 (Posted: 3 days ago) A federal judge has set key scheduling deadlines for the four first bellwether trials over claims that BioZorb breast markers are defectively designed. MORE ABOUT: BIOZORB LAWSUITLawyers in BioZorb Implant Lawsuits Request Updated Deadlines in Pretrial Schedule (10/15/2025)Tamoxifen Side Effects Linked to Uterine Tumors in Breast Cancer Patients: Study (09/16/2025)Five Women File Joint Lawsuit Over BioZorb Breast Implant Side Effects (09/09/2025) Lawsuits Over Depo-Provera and Meningioma To Be Coordinated Between Federal and State Courts (Posted: 4 days ago) Parties in federal Depo-Provera meningioma lawsuits seek closer coordination with Delaware and New York state courts, proposing a synchronization of general causation schedules. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Side Effects Hidden for Decades, Lawsuit Alleges (10/20/2025)Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (10/06/2025)Depo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)
Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (Posted: today) Breast mesh products marketed as “internal bras” for lift and augmentation surgeries are now under investigation amid reports of painful complications, and questions over manufacturers’ prior knowledge of mesh-related risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Problems Prompted FDA Warnings Over Off-Label Use (10/15/2025)Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Four BioZorb Breast Marker Lawsuits Set for Trial Between Jan. and April 2026 (Posted: 3 days ago) A federal judge has set key scheduling deadlines for the four first bellwether trials over claims that BioZorb breast markers are defectively designed. MORE ABOUT: BIOZORB LAWSUITLawyers in BioZorb Implant Lawsuits Request Updated Deadlines in Pretrial Schedule (10/15/2025)Tamoxifen Side Effects Linked to Uterine Tumors in Breast Cancer Patients: Study (09/16/2025)Five Women File Joint Lawsuit Over BioZorb Breast Implant Side Effects (09/09/2025)
Lawsuits Over Depo-Provera and Meningioma To Be Coordinated Between Federal and State Courts (Posted: 4 days ago) Parties in federal Depo-Provera meningioma lawsuits seek closer coordination with Delaware and New York state courts, proposing a synchronization of general causation schedules. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Side Effects Hidden for Decades, Lawsuit Alleges (10/20/2025)Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (10/06/2025)Depo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)